The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2017

Filed:

Jul. 16, 2013
Applicant:

Metabrain Research, Chilly Mazarin, FR;

Inventors:

Franck F. Lepifre, Saclay, FR;

Gersande R. Lena, Julienas, FR;

Valerie Autier, Gif sur Yvette, FR;

Micheline R. Kergoat, Bures sur Yvette, FR;

Lauren R. Faveriel, Longjumeau, FR;

Christine G. Charon, Gometz le Chatel, FR;

Sophie N. Raynal, Paris, FR;

Annick M. Audet, Leudeville, FR;

Assignee:

METABRAIN RESEARCH, Chilly Mazarin, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4025 (2006.01); C07D 493/14 (2006.01); C07D 333/24 (2006.01); C07D 333/34 (2006.01); C07D 333/38 (2006.01); C07D 333/40 (2006.01); C07H 9/04 (2006.01); C07D 409/04 (2006.01); C07D 409/06 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 417/06 (2006.01); A61K 31/381 (2006.01); A61K 31/4436 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 493/14 (2013.01); A61K 31/381 (2013.01); A61K 31/4025 (2013.01); A61K 31/4436 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 333/24 (2013.01); C07D 333/34 (2013.01); C07D 333/38 (2013.01); C07D 333/40 (2013.01); C07D 409/04 (2013.01); C07D 409/06 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 417/06 (2013.01); C07H 9/04 (2013.01);
Abstract

The present invention relates to a thiophene derivative of the following general formula I or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof or to its use as a drug in particular intended for treating and/or preventing diabetes, its complications and/or associated pathologies, advantageously diabetes of type II and hyperglycemia.


Find Patent Forward Citations

Loading…